More on Gardasil and Silgard from Portugal

A few weeks ago, we posted a piece on Gardasil in Portugal. João Jorge (Raul César Ferreira, Portugal) has kindly indicated that the Court decision on Gardasil stems from the Court of Appeal (Tribunal da Relação de Lisboa) and not from the 1st Instance Court (Tribunal do Comércio de Lisboa), as reported in our earlier posting. The decision maintained the 1st Instance Court decision (confirming the PTMO refusal decision).

Joao writes: "in Portugal several SPCs were applied for based on MAs for Gardasil/Silgard for several base patent, and that up to now and to my knowledge, one SPC has been granted." He has also provided the table below containing information on SPC applications regarding Gardasil/Silgard in Portugal:

Base Patent/(owner)	SPC number	Product / Medicament	Status
EP 647140 / (GEORGETOWNUNIVERSITY)	SPC 297	HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18] (RECOMBINANT, ADSORVED) /GARDASIL	Pending
	SPC 298	HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18] (RECOMBINANT, ADSORVED) /GARDASIL	Pending
	SPC 299	HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18] (RECOMBINANT, ADSORVED) /GARDASIL	Pending
	SPC 300	HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18] (RECOMBINANT, ADSORVED) /GARDASIL	Pending
	SPC 301	HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18] (RECOMBINANT, ADSORVED) /GARDASIL	Pending
EP 662132 / (U.S. GOV. BY THE SEC. DEP. HEALTH AND HUMAN SERV.)	SPC 257	PAPILLOMAVIRUS-LIKE PARTICLES /GARDASIL	REFUSED
	SPC 259	PAPILLOMAVIRUS-LIKE PARTICLES /GARDASIL	REFUSED
	SPC 261	PAPILLOMAVIRUS-LIKE PARTICLES /GARDASIL, SILGARD	REFUSED (awaits Court decision)
EP 688227 / (UNIV. OFROCHESTER)	SPC 255	- / SILGARD	REFUSED (awaits Court decision)
EP 817851 / (MERCK & CO., INC.)	SPC 258	PAPILLOMAVIRUS-LIKE PARTICLES /GARDASIL	REFUSED
	SPC 260	PAPILLOMAVIRUS-LIKE PARTICLES /GARDASIL, SILGARD	REFUSED (Courts maintained the decision)
	SPC 262	PAPILLOMAVIRUS-LIKE PARTICLES / SILGARD	REFUSED
EP 1015561 / (MEDIMMUNE, INC.)	SPC 256	PAPILLOMAVIRUS-LIKE PARTICLES /GARDASIL	Granted
EP 1165126 / (MERCK & CO. INC.)	SPC 266	PAPILLOMAVIRUS-LIKE PARTICLES /GARDASIL	REFUSED (awaits Court decision)
	SPC 267	PAPILLOMAVIRUS-LIKE PARTICLES /GARDASIL	REFUSED
	SPC 268	PAPILLOMAVIRUS-LIKE PARTICLES /GARDASIL, SILGARD	Granted

Correction - there are two SPCs granted so far:

SPC 256 to Medimmune based on EP1015561
SPC268 to Merck & Co. based on EP1165126 (here for the register extract)

Thanks to Andreas Schmidtt for letting us know.